Alkynyl nicotinamides show antileukemic activity in drug-resistant acute myeloid leukemia is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Health
Grant: R01CA173852,R01CA134777,R01HL146137,R01HL140961,R21CA263470,R21CA263239,5R44CA217134
NCI NIH HHS
Grant: R01 CA173852
NHLBI NIH HHS
Grant: R01 HL140961
NCI NIH HHS
Grant: R44 CA247134
NIH HHS
Grant: S10 OD030430
NCI NIH HHS
Grant: P30 CA082709
NCI NIH HHS
Grant: R01 CA134777
National Institutes of Health
Grant: 5R01CA173852-10
Role of p21 activated kinase in Leukemogenesis
National Institutes of Health
Grant: 1U18TR004146-01
Chemical instruments-aware distributed blockchain based open AI platform to accelerate drug discovery
National Institutes of Health
Grant: 5R01CA134777-08
Role of Shp2 in FLT3-ITD induced leukemogenesis
National Institutes of Health
Grant: 5R21CA263239-02
Novel drug to treat poor prognosis AML
National Institutes of Health
Grant: 5R21CA263470-02
Dual anti-leukemic and cardio protective role for ROCK
National Institutes of Health
Grant: 5R01HL146137-03
Targeting Novel Pathways in JMML
National Institutes of Health
Grant: 1R01HL140961-01A1
Hyperglycemia mediated myeloproliferative disease
Fields of Study
MeSH Terms
Keywords